These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 2182432
1. Intensive chemotherapy for acute lymphoblastic leukaemia in adults. Rohatiner AZ, Bassan R, Battista R, Barnett MJ, Gregory W, Lim J, Amess J, Oza A, Barbui T, Horton M. Haematol Blood Transfus; 1990; 33():413-8. PubMed ID: 2182432 [No Abstract] [Full Text] [Related]
6. Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy. Grenzebach J, Schrappe M, Ludwig WD, Parwaresch R, Zimmermann M, Gadner H, Riehm H, Reiter A, BFM-Group. Ann Hematol; 2001; 80 Suppl 3():B73-6. PubMed ID: 11757713 [Abstract] [Full Text] [Related]
7. [Intensive induction and early consolidation of acute lymphoid leukemia in the adult. A pilot study of feasibility and long-term development]. Fière D, Marty M, Solal-Celigny P, Harousseau JL, Gorin NC, Desablens B, Brière J, David B, Bordessoule D, Hayat M. Presse Med; 1989 Feb 11; 18(5):221-3. PubMed ID: 2522209 [Abstract] [Full Text] [Related]
8. Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group. Matsuzaki A, Ishii E, Nagatoshi Y, Eguchi H, Koga H, Yanai F, Inada H, Nibu K, Tamai Y, Akiyoshi K, Nakayama H, Hara T, Take H, Miyazaki S, Okamura J. Int J Hematol; 2001 Apr 11; 73(3):369-77. PubMed ID: 11345205 [Abstract] [Full Text] [Related]
11. Long-term survival in acute lymphoblastic leukaemia in adults: a prospective study of 51 patients. Finnish Leukaemia Group. Eur J Haematol; 1992 Feb 11; 48(2):75-82. PubMed ID: 1547879 [Abstract] [Full Text] [Related]
12. Improved prognosis for childhood acute lymphocytic leukemia with very high white blood cell count (greater than 100/nl) with rotation of non-cross-resistant drug combinations. Janka-Schaub GE, Goebel U, Graubner U, Haas RJ, Juergens H, Spaar HJ, Winkler K. Haematol Blood Transfus; 1990 Feb 11; 33():489-93. PubMed ID: 2182442 [No Abstract] [Full Text] [Related]
13. Prognosis after relapse in acute lymphoblastic leukemia in childhood. Gustafsson G, Kreuger A. Pediatr Hematol Oncol; 1986 Feb 11; 3(2):119-26. PubMed ID: 3153221 [Abstract] [Full Text] [Related]
14. Adult acute lymphoblastic leukemia: results of an aggressive regimen in India. Raje N, Pai S, Vaidya S, Gopal R, Parikh P, Saikia T, Pai V, Nadkarni K, Advani IM. Leuk Lymphoma; 1994 Jul 11; 14(3-4):285-90. PubMed ID: 7950917 [Abstract] [Full Text] [Related]
15. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Hann I, Vora A, Harrison G, Harrison C, Eden O, Hill F, Gibson B, Richards S, UK Medical Research Council's Working Party on Childhood Leukaemia. Br J Haematol; 2001 Apr 11; 113(1):103-14. PubMed ID: 11328289 [Abstract] [Full Text] [Related]
16. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy. Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, Botsonis A, Tsangaris GT. J Pediatr Hematol Oncol; 2001 Dec 11; 23(9):591-7. PubMed ID: 11902303 [Abstract] [Full Text] [Related]
17. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia. Hann I, Vora A, Richards S, Hill F, Gibson B, Lilleyman J, Kinsey S, Mitchell C, Eden OB. Leukemia; 2000 Mar 11; 14(3):356-63. PubMed ID: 10720126 [Abstract] [Full Text] [Related]
18. Acute lymphoblastic leukaemia presenting as breast mass. Jain AK, Gupta RC, Bhardwaj B, Leelani N. J Assoc Physicians India; 1992 May 11; 40(5):335-6. PubMed ID: 1483996 [Abstract] [Full Text] [Related]
19. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G. Haematologica; 1998 Sep 11; 83(9):791-9. PubMed ID: 9825576 [Abstract] [Full Text] [Related]